Skip to main content Skip to main menu
UF Health University of Florida
Division of Hematology & Oncology Department of Medicine in the College of Medicine
Molly W Mandernach

Molly W Mandernach, MD, MPH

Professor

Department: MD-HEMATOLOGY-ONCOLOGY
Business Phone: (352) 273-7832
Business Email: mweidner@ufl.edu

On This Page

About Molly W Mandernach

Dr. Mandernach is a Clinical Associate Professor of Medicine within the division of hematology and oncology, and serves as a clinician educator with a focus on thrombosis and hemostasis and sickle cell disease. She is a member of the American Society of Hematology.

Teaching Profile

Courses Taught

  1. PAS5010 – Intro to Medicine 1

    College of Medicine

  2. BMS6631 – Hematology

    College of Medicine

  3. MDC7200 – Medicine Clerkship

    College of Medicine

  4. MDC6001 – Intro Clin Practice

    College of Medicine

Board Certifications

  • Hematology
    American Board of Internal Medicine
  • Internal Medicine
    American Board of Internal Medicine
  • Oncology
    American Board of Internal Medicine

Clinical Profile

Specialties

  • Cancer
  • Hematology
  • Hematology and Oncology

Areas of Interest

  • Deep Vein Thrombosis
  • Sickle Cell Disease

Publications

Academic Articles

Grants

  1. CTOA

    Active

    Role:
    Principal Investigator
    Funding:
    UNIV OF FLORIDA

  2. Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain

    Role:
    Co-Investigator
    Funding:
    UNIV OF ILLINOIS CHICAGO via NATL CTR FOR COMPLEM AND INTEGRATIVE HLT

  3. Education and Mentoring to Bring Access to Comprehensive Care (EMBRACE) Network

    Active

    Role:
    Principal Investigator
    Funding:
    UNIV OF ALABAMA BIRMINGHAM via US HLTH RESOURCES AND SERV ADMN

  4. Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain

    Role:
    Co-Investigator
    Funding:
    UNIV OF ILLINOIS CHICAGO via NATL INST OF HLTH NINDS

  5. A Stress and Pain Self-management m-Health App for Adult Outpatients with Sickle Cell Disease

    Active

    Role:
    Co-Investigator
    Funding:
    NATL INST OF HLTH NINR

  6. A Phase II, multicenter, randomized, open label two arm study comparing the effect of crizanlizumab + standard of care to standard of care alone on renal function in sickle cell disease patients = 16 years with chronic kidney disease due to sickle cell nephropathy (STEADFAST)

    Role:
    Principal Investigator
    Funding:
    NOVARTIS PHARMACEUTICALS CORP

  7. A Phase 3, Double-blind, Randomized, Placebo-controlled, Multicenter Study of GBT440 Administered Orally to Patients With Sickle Cell Disease

    Role:
    Principal Investigator
    Funding:
    GLOBAL BLOOD THERAPEUTICS

Education

  1. Fellowship – Hematology Oncology

    University of Florida

  2. Residency – Internal Medicine

    University of Florida

  3. Medical Degree

    University of Florida

  4. Master of Public Health

    University of South Florida

Contact Details

Phones:
Business:
(352) 273-7832
Emails:
Business:
mweidner@ufl.edu
Addresses:
Business Mailing:
PO Box 100278
 GAINESVILLE FL 32610
Business Street:
1600 SW ARCHER RD
 GAINESVILLE FL 32610